reports
Inchcape: 1 director
A director at Inchcape bought 15,000 shares at 724p and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...
DAVIDsTEA to Commence Trading on the TSX Venture Exchange and Delist f...
DAVIDsTEA to Commence Trading on the TSX Venture Exchange and Delist from Nasdaq - Trading on the TSX Venture Exchange to start on April 3, 2023 - DAVIDsTEA to delist from Nasdaq at the close of markets on April 14, 2023 MONTREAL, March 27, 2023 (GLOBE NEWSWIRE) -- DAVIDsTEA Inc. (Nasdaq: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, is pleased to announce that the Company has been accepted for listing on the TSX Venture Exchange (“TSXV”) and that the Company’s common shares will commence trading on the TSXV on Monday, April 3, 2023 under the ticker symb...
DAVIDsTEA fera son entrée à la Bourse de croissance TSX et se retirera...
DAVIDsTEA fera son entrée à la Bourse de croissance TSX et se retirera du Nasdaq - La négociation à la Bourse de croissance TSX débutera le 3 avril 2023 - DAVIDsTEA sera radiée du Nasdaq à la clôture des marchés le 14 avril 2023 MONTRÉAL, 27 mars 2023 (GLOBE NEWSWIRE) -- Les Thés DAVIDsTEA inc. (Nasdaq : DTEA) (« Les Thés DAVIDsTEA » ou la « Société »), l’un des premiers marchands de thé en Amérique du Nord, sont heureux d'annoncer que l’inscription de la Société à la Bourse de croissance TSX (« TSXV ») a été acceptée et que les actions ordinaires de la Société commenceront à être n...
- Oliver Metzger
- Stephan Wulf
BioNTech SE : Strong Q4 2022 figures – 2023 guidance disappointing
>FY22 Q4 figures topped beat our expectations and those of the market - Q4 revenues was € 4.278m, beating our estimate of € 3,850m and the consensus forecast of € 3,950m. As a result of the development of the coronavirus pandemic BioNTech’s top line declined y-o-y by 23%. EBIT was at € 3.293m vs our estimates of € 2,743m and the consensus forecast of € 2,817m. The EBIT margin declined y-o-y by nearly 800bp to 77%. BioNTech is guiding for 2023 Covid-19 vac...
BioSig Announces New Advisory Board Member Edwin Wang
BioSig Announces New Advisory Board Member Edwin Wang Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of new Advisory Board member Edwin Wang. Mr. Wang has over 20 years of impactful experience in private equity, venture capital, merchant banking, and family office investing. He is the founder of Accretive Capital Partners LLC, a p...
LianBio Reports Fourth Quarter and Full Year 2022 Financial Results an...
LianBio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update Phase 3 trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) ongoing, with data expected mid-year 2023 Phase 3 registrational trial of TP-03 in Chinese patients with Demodex blepharitis ongoing, with data expected in the fourth quarter of 2023 Entered into commercial agreement with Pfizer, with Pfizer opting into LianBio rights to RSV therapeutic candidate sisunatovir in LianBio territories Cash, cash equivalents and marketable securities of...
Pidilite Industries Ltd: 1 director
A director at Pidilite Industries Ltd sold 36,000 shares at 2,354.073INR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Asiasoft Corporation PLC: 1 director
A director at Asiasoft Corporation PLC bought 17,595,300 shares at 16.511THB and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Medigus: Viewbix Reports its Financial Results for 2022 with a 114% Gr...
Medigus: Viewbix Reports its Financial Results for 2022 with a 114% Growth in Revenues Totaling $97 Million Viewbix is a subsidiary of Gix Internet whose results are consolidated with Medigus’ financial statements Tel Aviv, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Viewbix Inc. (henceforth “Viewbix”) (OTC: VBIX), 76% owned by Medigus’ subsidiary Gix Internet, (henceforth “Gix”) (42.25% owned by Me...
Gulf Island Announces Fourth Quarter and Full-Year 2022 Results Confer...
Gulf Island Announces Fourth Quarter and Full-Year 2022 Results Conference Call Date HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI), a leading steel fabricator and service provider to the industrial and energy sectors, today announced that it will report financial results for the fourth quarter and full-year 2022 after the market close on Tuesday, March 28, 2023. Gulf Island management will hold a conference call on Tuesday, March 28, 2023, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss the Company’...
Innovative Producer, Filmmaker and Author Mick Ebeling to Join Duck C...
Innovative Producer, Filmmaker and Author Mick Ebeling to Join Duck Creek’s Formation ’23 as Keynote Speaker Ebeling will discuss pushing the bar and making the inconceivable, the unbelievable and the impossible, not impossible Boston, March 27, 2023 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, welcomes Mick Ebeling as its keynote speaker. Formation, Duck Creek’s annual user conference, attracts the world’s leading insurance industry and technology minds and takes place in Orla...
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Fin...
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Data to be presented at AACR demonstrate significant SP-3164 anticancer activity in both non-Hodgkin Lymphoma and Multiple Myeloma cell lines and animal models Targeted protein degrader SP-3164 on track for IND submission in first half of 2023 with clinical trial to begin in second half of 2023 HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies fo...
NanoXplore Announces Purchase of Martinrea International’s Stake in Vo...
NanoXplore Announces Purchase of Martinrea International’s Stake in VoltaXplore and Confirms Extension of Their Graphene Commercial Agreement MONTREAL, March 27, 2023 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, and Martinrea International Inc. (“Martinrea”), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value added Lightweight Structures and Propulsion Systems, through its subsidiary, Martinrea Innovation Developments Inc. (“M...
NanoXplore annonce le rachat de la participation de Martinrea Internat...
NanoXplore annonce le rachat de la participation de Martinrea International dans VoltaXplore et confirme l’extension de leur entente commerciale sur le graphène MONTRÉAL, 27 mars 2023 (GLOBE NEWSWIRE) -- NanoXplore Inc. (« NanoXplore » ou « la Société ») (TSX : GRA et OTCQX : NNXPF), chef de file mondial dans le domaine du graphène, et Martinrea International Inc. (« Martinrea »), équipementier automobile diversifié et mondial engagé dans la conception, le développement et la fabrication de structures légères et de systèmes de propulsion à forte valeur ajoutée, par l'intermédiaire de sa f...
The NFT Gaming Company now using ChatGPT and Midjourney to Develop its...
The NFT Gaming Company now using ChatGPT and Midjourney to Develop its Artificial Intelligence Gaming Portfolio. Roseland, NJ , March 27, 2023 (GLOBE NEWSWIRE) -- The NFT Gaming Company, Inc. ("NFTG" or the "Company"), a company developing a digital gaming platform and community that will offer users the ability to mint unique avatars playable in all of the games on the platform in the form of non-fungible tokens, or “NFTs,” today announced that it started using ChatGPT and MidJourney AI to develop its portfolio of AI-based games. “We are thrilled to incorporate ChatGPT and Midjourney to...
Ambrx to Present Preclinical Data on ARX517 and ARX305 at the 2023 AAC...
Ambrx to Present Preclinical Data on ARX517 and ARX305 at the 2023 AACR Annual Meeting Three posters will be presented at AACR and include data from preclinical studies of ARX517 and ARX305 and Trial in Progress Poster on APEX-01 SAN DIEGO, March 27, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), announced the presentation of three posters featuring preclinical data at the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida, from April 14 to 19, 2023. The two preclinical posters will provide data from Ambrx’s preclini...
US Nuclear Corp – Cali from Above Restructuring
US Nuclear Corp – Cali from Above Restructuring LOS ANGELES, CA, March 27, 2023 (GLOBE NEWSWIRE) -- via -- On March 3, 2023, US Nuclear Corp (UCLE) sold its interest in Cali from Above, a private company engaged in the business of UAV/drone sales and drone services, located in Canoga Park, California to its President and Chief Executive Officer, Robert Goldstein, in consideration of UCLE receiving 65,000,000 shares of common stock in Averox, Inc. (OTC: AVRI) resulting in UCLE owning approximately 26% of issued and outstanding shares of common stock in AVRI. Mr. Goldstein commented, “We b...
Navigator Holdings Ltd. Announces Additional Vessel Acquisitions Under...
Navigator Holdings Ltd. Announces Additional Vessel Acquisitions Under 60/40 Joint Venture With Greater Bay Gas NEW YORK and LONDON, March 27, 2023 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (“Navigator” or “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, is pleased to announce the third and fourth vessel acquisitions under its 60/40 joint venture with Greater Bay Gas Co. Ltd. (Liberia) (“Greater Bay Gas”), (the “Joint Venture”), previously announced on September 30, 2022. The Joint Venture announced the purchase of the fir...
- FIMA Research
Fima Daily Insight 27 March 2023
Please find enclosed our daily market report.Market CommentCroatia Hrvatski Telekom proposes higher dividend for 2022 (DIVY 4.3%) Turisthotel CEO, trade union slam Tankerska buyout offer Slovenia Business sentiment further down in March Housing prices up 11.3% in 2022 and by 78% since 2015 JSI report shows Unior leak did not harm people's health Romania OMV Petrom to receive EUR 88 mil from the National Recovery and Resilience Plan for a green Hidrogen instalation investement ...
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 27-March-2023 / 13:20 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.